“These defendants preyed totally on older customers with false or unsubstantiated claims about curing diabetes and free cash from the federal government,” Daniel Kaufman, Bureau of Client Safety appearing director, stated in a information launch. “The FTC has an extended historical past of taking authorized motion in opposition to misleading claims akin to these, and firms that fail to substantiate their scientific and monetary representations can anticipate to face the implications.”
